[go: up one dir, main page]

AU2017901611A0 - Compounds for the treatment of respiratory diseases - Google Patents

Compounds for the treatment of respiratory diseases

Info

Publication number
AU2017901611A0
AU2017901611A0 AU2017901611A AU2017901611A AU2017901611A0 AU 2017901611 A0 AU2017901611 A0 AU 2017901611A0 AU 2017901611 A AU2017901611 A AU 2017901611A AU 2017901611 A AU2017901611 A AU 2017901611A AU 2017901611 A0 AU2017901611 A0 AU 2017901611A0
Authority
AU
Australia
Prior art keywords
compounds
treatment
respiratory diseases
respiratory
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2017901611A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Melbourne
Original Assignee
University of Melbourne
Filing date
Publication date
Application filed by University of Melbourne filed Critical University of Melbourne
Publication of AU2017901611A0 publication Critical patent/AU2017901611A0/en
Priority to US16/610,168 priority Critical patent/US20200079757A1/en
Priority to PT187950977T priority patent/PT3619204T/en
Priority to ES18795097T priority patent/ES3049333T3/en
Priority to AU2018262108A priority patent/AU2018262108A1/en
Priority to PCT/AU2018/050404 priority patent/WO2018201192A1/en
Priority to JP2019560254A priority patent/JP7788128B2/en
Priority to EP18795097.7A priority patent/EP3619204B1/en
Priority to CN201880039084.6A priority patent/CN110753688A/en
Priority to FIEP18795097.7T priority patent/FI3619204T3/en
Priority to US17/690,855 priority patent/US20220380343A1/en
Priority to AU2022202774A priority patent/AU2022202774A1/en
Priority to JP2023101906A priority patent/JP2023134493A/en
Priority to AU2024200521A priority patent/AU2024200521B2/en
Abandoned legal-status Critical Current

Links

AU2017901611A 2017-05-03 2017-05-03 Compounds for the treatment of respiratory diseases Abandoned AU2017901611A0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FIEP18795097.7T FI3619204T3 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
EP18795097.7A EP3619204B1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
CN201880039084.6A CN110753688A (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
ES18795097T ES3049333T3 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
AU2018262108A AU2018262108A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
PCT/AU2018/050404 WO2018201192A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
JP2019560254A JP7788128B2 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
US16/610,168 US20200079757A1 (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
PT187950977T PT3619204T (en) 2017-05-03 2018-05-03 Compounds for the treatment of respiratory diseases
US17/690,855 US20220380343A1 (en) 2017-05-03 2022-03-09 Compounds for the treatment of respiratory diseases
AU2022202774A AU2022202774A1 (en) 2017-05-03 2022-04-27 Compounds for the treatment of respiratory diseases
JP2023101906A JP2023134493A (en) 2017-05-03 2023-06-21 Compounds for the treatment of respiratory diseases
AU2024200521A AU2024200521B2 (en) 2017-05-03 2024-01-29 Compounds for the treatment of respiratory diseases

Publications (1)

Publication Number Publication Date
AU2017901611A0 true AU2017901611A0 (en) 2017-05-18

Family

ID=

Similar Documents

Publication Publication Date Title
EP3448874A4 (en) Compositions for the treatment of disease
EP3448987A4 (en) Compositions for the treatment of disease
IL253062B (en) Pyrazine compounds for the treatment of infectious diseases
EP3481402A4 (en) Compounds, compositions, and methods for the treatment of disease
ZA201908165B (en) Compounds for the prevention and treatment of diseases and the use thereof
SI3672954T1 (en) Compounds, salts thereof and their use for the treatment of diseases
EP3684418B8 (en) Compounds for the treatment of cysteamine sensitive disorders
EP3268086A4 (en) Lsd for the treatment of alzheimer's disease
SMT201900172T1 (en) 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
EP3484504A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3448851B8 (en) Di-substituted pyrazole compounds for the treatment of diseases
ZA201906213B (en) Compounds and methods for the treatment of parasitic diseases
EP3877383A4 (en) Compounds and compositions for the treatment of respiratory diseases
PT3619204T (en) Compounds for the treatment of respiratory diseases
PL3761982T3 (en) Use of nalfurafine for the treatment of demyelinating diseases
EP3283457A4 (en) Compounds and methods for the treatment of neurodegenerative diseases
EP3630754B8 (en) Isoindoline-acetylene compounds for the treatment of cancer
EP3534954A4 (en) Compounds for treatment of neurodegenerative diseases
EP3448377A4 (en) Methods for the treatment of infection
EP3242681B8 (en) Novel compounds for the treatment of cancer
PL3710043T3 (en) Fgf10 for the treatment of heart diseases
EP3507277B8 (en) Hydroxynorketamine derivatives for the treatment of disorders
HK40061035A (en) Novel compounds for the treatment of respiratory diseases
AU2017901647A0 (en) Compounds for the treatment of respiratory diseases
AU2017901611A0 (en) Compounds for the treatment of respiratory diseases